देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
METFORMIN HYDROCHLORIDE
AVANSTRA INC
A10BA02
METFORMIN
850MG
TABLET
METFORMIN HYDROCHLORIDE 850MG
ORAL
100
Prescription
BIGUANIDES
Active ingredient group (AIG) number: 0101773002; AHFS:
CANCELLED POST MARKET
2014-08-21
_ _ _Product Monograph _ _Page 1 of 34_ PRODUCT MONOGRAPH Pr AVA-METFORMIN metformin hydrochloride tablets House standard 500 and 850 mg Oral antihyperglycemic agent Avanstra Inc. 10761 – 25th NE Suite 110, Building “B” Calgary, Alberta T2C 3C2 Canada Date of Preparation: February 21, 2011 Submission Control No: 145186 _ _ _Product Monograph _ _Page 2 of 34_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .........................................................3 SUMMARY PRODUCT INFORMATION.........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS....................................................................................................3 WARNINGS AND PRECAUTIONS ..................................................................................4 ADVERSE REACTIONS ..................................................................................................11 DRUG INTERACTIONS...................................................................................................12 DOSAGE AND ADMINISTRATION ..............................................................................15 OVERDOSAGE.................................................................................................................15 ACTION AND CLINICAL PHARMACOLOGY.............................................................16 STORAGE AND STABILITY ..........................................................................................16 DOSAGE FORMS, COMPOSITION AND PACKAGING..............................................17 PART II: SCIENTIFIC INFORMATION................................................................................18 PHARMACEUTICAL INFORMATION ..........................................................................18 CLINICAL TRIALS ..........................................................................................................19 DETAILED PHA पूरा दस्तावेज़ पढ़ें